HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Franziska Reipsch Selected Research

1-methylimidazole

12/2021Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Franziska Reipsch Research Topics

Disease

2Neoplasms (Cancer)
12/2021 - 05/2017
1Colorectal Neoplasms (Colorectal Cancer)
12/2021
1Neoplasm Metastasis (Metastasis)
12/2021
1Ovarian Neoplasms (Ovarian Cancer)
05/2017

Drug/Important Bio-Agent (IBA)

1Alkenes (Olefins)IBA
12/2021
1imidazoleIBA
12/2021
1TubulinIBA
12/2021
1brimaminIBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1fosbretabulin (combretastatin A4)IBA
12/2021
11-methylimidazoleIBA
12/2021
1Cytostatic AgentsIBA
05/2017
1Tinzaparin (Innohep)FDA Link
05/2017
1Cisplatin (Platino)FDA LinkGeneric
05/2017
1Heparin (Liquaemin)FDA LinkGeneric
05/2017
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
05/2017

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2021
1Therapeutics
05/2017